New cancer drug injected directly into tumors shows early promise
NCT ID NCT05549804
Summary
This early-stage study tested the safety of an experimental drug called KL340399 when injected directly into tumors. The trial involved 6 patients with advanced solid cancers who had exhausted standard treatment options. Researchers aimed to find the highest safe dose and gather initial information about how the drug affects tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Conditions
Explore the condition pages connected to this study.